MedPath
HSA Approval

UROMITEXAN TABLETS 400 mg

SIN10703P

UROMITEXAN TABLETS 400 mg

UROMITEXAN TABLETS 400 mg

January 25, 1999

BAXTER HEALTHCARE (ASIA) PTE LTD

BAXTER HEALTHCARE (ASIA) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantBAXTER HEALTHCARE (ASIA) PTE LTD
Licence HolderBAXTER HEALTHCARE (ASIA) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

V03AF01

mesna

Manufacturer Information

BAXTER HEALTHCARE (ASIA) PTE LTD

TEMMLER PHARMA GMBH

Active Ingredients

MESNA

400 mg

Coenzyme M

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

UROMITEXAN TABLETS 400 mg - HSA Approval | MedPath